The nation of Zimbabwe has turned down a substantial US health deal valued at $367m (272 million pounds) spanning five years over Washington's insistence on sensitive data.
The decision became public following a internal memorandum from December was leaked, which showed President Emmerson Mnangagwa believed the deal was "lopsided".
A government representative has since explained that the United States was seeking genetic material for research and commercial gain but was unwilling to share the resulting advantages from any future treatments.
"We must now begin the challenging and unfortunate process of scaling back our support in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.
The US Embassy said the US had provided more than $1.9bn in health funding to Zimbabwe during the past two decades.
A medical body in Zimbabwe has called for more dialogue to find a agreement agreeable to both sides so the country's critical HIV treatment initiative can be sustained.
Broader Implications
This rejection comes after a comparable case in Kenya, where a high court halted a related deal with the US after legal challenges were filed about the security of citizens' health data.
Since returning to the presidency last year, US President Donald Trump has reduced foreign aid and shut down the key foreign aid agency.
USAID had overseen aid for the American government, but Trump argued its expenditure was "inefficient" and his government was pursuing direct bilateral agreements to enhance openness and accountability.
Based on reports, 16 African countries have to date signed these new health pacts, constituting over $18.3bn of fresh investment.
Details of the Declined Agreement
This assistance for Zimbabwe was intended to gone towards "tackling HIV/Aids, TB, malaria, maternal and child health, and preparing for epidemics".
"We believe this partnership would have delivered significant benefits for Zimbabwean communities, especially the 1.2 million presently receiving antiretroviral therapy via US-supported programmes," the Ambassador added.
However, government spokesperson Nick Mangwana argued the arrangement was "unfair".
"Zimbabwe was being asked to surrender its biological resources and data over an extended period, with no corresponding promise of access to any scientific breakthroughs – such as new medicines or tests – that could be developed from that shared data," Mangwana explained.
"Effectively, our nation would provide the basic resources for scientific discovery with no assurance that the final treatments would be accessible to our people should a new pandemic arise."
National Interest and International Frameworks
He also noted that the American exit from the World Health Organization (WHO) and its push of bilateral health agreements were undermining systems already set up through the global organization.
The spokesperson gave as an example its Pandemic Benefit-Sharing scheme created to deal with future global health emergencies.
"This system is designed to guarantee that when a country provides its data, the resulting advantages – including vaccines and treatments – are shared equitably, not commercialised exclusively by those with the funds to develop them."
Zimbabwe's reservations over the US deal "should not be misconstrued as hostility towards the US," he added.
"We welcome further dialogue with our American counterparts on how subsequent co-operation could be structured in a way that honours the independence and interests of both nations."
Health Experts Response
A leading public health body stated it recognised the official position, but recommended that talks must proceed given that much of the country's HIV programmes depended on foreign aid.
"In cases where technical issues arise, including those relating to data governance or agreement terms, these can frequently be addressed via detailed discussion and mutually agreed protections," it commented.
The halted deal highlights the ongoing tensions between accepting much-needed international aid and protecting national sovereignty in an increasingly data-driven world.